Remote Medical Science Liaison – Radiopharmaceuticals

Lantheus; Washington (Washington County); On-site; USD 156,000 - 234,000; Full time

Benefits offered by this job

Health benefits

401(k) with company contribution

Paid time off

Parental leave

Job summary

Lantheus, a leader in radiopharmaceuticals, is seeking a Medical Science Liaison to build peer-to-peer relationships with healthcare professionals across the United States. This remote role requires engaging KOLs, investigators, and academic institutions to share evidence and discuss diagnostic imaging and radiopharmaceuticals.

You will support clinical research, generate medical insights, and collaborate across Medical Affairs, Clinical Development, Regulatory, and Market Access while adhering

Qualifications

• PhD, PharmD, MD, DO, or equivalent advanced degree required.
• Minimum of two years of MSL or Medical Affairs experience preferred.
• Clinical or scientific experience in radiopharmaceuticals or diagnostic imaging preferred.
• Strong scientific acumen and ability to communicate complex information.

Responsibilities

• Develop, cultivate, and maintain strategic long-term scientific relationships with HCPs, KOLs, investigators, and academia.
• Provide actionable medical insights to inform strategy and priorities.
• Represent Medical Affairs at congresses and meetings.
• Ensure compliant scientific discussions and accurate dissemination of information.

Skills

KOL relationship management

Scientific communication

Medical science liaison

Clinical research understanding

Travel readiness

Education

Doctoral or medical degree

Job description

Lantheus, a leader in radiopharmaceuticals, is seeking a Medical Science Liaison to build peer-to-peer relationships with healthcare professionals across the United States. This remote role requires engaging KOLs, investigators, and academic institutions to share evidence and discuss diagnostic imaging and radiopharmaceuticals.

You will support clinical research, generate medical insights, and collaborate across Medical Affairs, Clinical Development, Regulatory, and Market Access while adhering